Exercise Testing in Mitral Regurgitation.

[en] Mitral regurgitation (MR) is the second most common valvular heart disease referred for corrective surgery. Diagnostic and management dilemmas are not uncommon when dealing with MR patients. Exercise testing plays an important role in sorting out some of these clinical challenges. In primary asymptomatic MR, exercise testing allows symptom assessment, confident link of symptoms to valve disease severity, safe deferral of surgery for the next 1-year in patients with preserved exercise capacity, insights into the mechanism of exercise-induced dyspnea and helps in individual risk stratification. Moreover, exercise testing in the form of exercise stress echocardiography is also useful in the evaluation of patients with secondary ischemic MR for risk stratification as well as for the detection of patients with moderate ischemic MR in whom mitral valve repair at the time of surgical revascularization may add benefit.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

DULGHERU, Raluca Elena ; Centre Hospitalier Universitaire de Liège - CHU > Service de cardiologie

MARCHETTA, Stella ; Centre Hospitalier Universitaire de Liège - CHU > Service de cardiologie

Sugimoto, Tadafumi

Go, Yun Yun

Girbea, Alexandra

Oury, Cécile ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : GIGA - Cardiovascular Sciences

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Imagerie cardiaque fonctionnelle par échographie

Language :

English

Title :

Exercise Testing in Mitral Regurgitation.

Publication date :

2017

Journal title :

Progress in Cardiovascular Diseases

ISSN :

0033-0620

eISSN :

1532-8643

Publisher :

W. B. Saunders Co., United Kingdom

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 24 February 2018

Statistics

Number of views

510 (5 by ULiège)

Number of downloads

872 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Iung, B., Baron, G., Butchart, E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J 24 (2003), 1231–1243.
Vahanian, A., Alfieri, O., Andreotti, F., et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33 (2012), 2451–2496.
Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 70 (2017), 252–289.
Enriquez-Sarano, M., Avierinos, J.F., Messika-Zeitoun, D., et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352 (2005), 875–883.
Detaint, D., Sundt, T.M., Nkomo, V.T., et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation 114 (2006), 265–272.
Feldman, T., Kar, S., Elmariah, S., et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 66 (2015), 2844–2854.
Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2438–2488.
Rusinaru, D., Tribouilloy, C., Grigioni, F., et al. Left atrial size is a potent predictor of mortality in mitral regurgitation due to flail leaflets: results from a large international multicenter study. Circ Cardiovasc Imaging 4 (2011), 473–481.
Barbieri, A., Bursi, F., Grigioni, F., et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 32 (2011), 751–759.
Eguchi, K., Ohtaki, E., Matsumura, T., et al. Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. Eur Heart J 26 (2005), 1866–1872.
Magne, J., Mahjoub, H., Dulgheru, R., et al. Left ventricular contractile reserve in asymptomatic primary mitral regurgitation. Eur Heart J 35 (2014), 1608–1616.
Magne, J., Lancellotti, P., Pierard, L.A., Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol 56 (2010), 300–309.
Magne, J., Donal, E., Mahjoub, H., et al. Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation. Heart 101 (2015), 391–396.
Magne, J., Mahjoub, H., Pibarot, P., et al. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation. Eur J Heart Fail 14 (2012), 1293–1302.
Magne, J., Lancellotti, P., Pierard, L.A., Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 122 (2010), 33–41.
Suzuki, K., Izumo, M., Yoneyama, K., et al. Influence of exercise-induced pulmonary hypertension on exercise capacity in asymptomatic degenerative mitral regurgitation. J Cardiol 66 (2015), 246–252.
Naji, P., Griffin, B.P., Asfahan, F., et al. Predictors of long-term outcomes in patients with significant myxomatous mitral regurgitation undergoing exercise echocardiography. Circulation 129 (2014), 1310–1319.
Naji, P., Griffin, B.P., Barr, T., et al. Importance of exercise capacity in predicting outcomes and determining optimal timing of surgery in significant primary mitral regurgitation. J Am Heart Assoc, 3, 2014, e001010.
Messika-Zeitoun, D., Johnson, B.D., Nkomo, V., et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J Am Coll Cardiol 47 (2006), 2521–2527.
Lancellotti, P., Pellikka, P.A., Budts, W., et al. The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 17 (2016), 1191–1229.
Guazzi, M., Arena, R., Halle, M., et al. 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J, 2016, 10.1093/eurheartj/ehw180 [pii: ehw180. Epub ahead of print].
Guazzi, M., Cahalin, L.P., Arena, R., Cardiopulmonary exercise testing as a diagnostic tool for the detection of left-sided pulmonary hypertension in heart failure. J Card Fail 19 (2013), 461–467.
Coisne, A., Levy, F., Malaquin, D., et al. Feasibility of Doppler hemodynamic evaluation of primary and secondary mitral regurgitation during exercise echocardiography. Int J Cardiovasc Imaging 31 (2015), 291–299.
Kusunose, K., Popovic, Z.B., Motoki, H., Marwick, T.H., Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging 6 (2013), 167–176.
Lee, R., Hanekom, L., Marwick, T.H., Leano, R., Wahi, S., Prediction of subclinical left ventricular dysfunction with strain rate imaging in patients with asymptomatic severe mitral regurgitation. Am J Cardiol 94 (2004), 1333–1337.
Naji, P., Asfahan, F., Barr, T., et al. Impact of duration of mitral regurgitation on outcomes in asymptomatic patients with myxomatous mitral valve undergoing exercise stress echocardiography. J Am Heart Assoc, 4, 2015, 10.1161/JAHA.114.001348 [pii:e001348].
Magne, J., Lancellotti, P., O'Connor, K., et al. Prediction of exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. J Am Soc Echocardiogr 24 (2011), 1004–1012.
Tolle, J.J., Waxman, A.B., Van Horn, T.L., Pappagianopoulos, P.P., Systrom, D.M., Exercise-induced pulmonary arterial hypertension. Circulation 118 (2008), 2183–2189.
Mahjoub, H., Levy, F., Cassol, M., et al. Effects of age on pulmonary artery systolic pressure at rest and during exercise in normal adults. Eur J Echocardiogr 10 (2009), 635–640.
Lewis, G.D., Murphy, R.M., Shah, R.V., et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 4 (2011), 276–285.
Lee, R., Haluska, B., Leung, D.Y., et al. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart 91 (2005), 1407–1412.
Haluska, B.A., Short, L., Marwick, T.H., Relationship of ventricular longitudinal function to contractile reserve in patients with mitral regurgitation. Am Heart J 146 (2003), 183–188.
Donal, E., Mascle, S., Brunet, A., et al. Prediction of left ventricular ejection fraction 6 months after surgical correction of organic mitral regurgitation: the value of exercise echocardiography and deformation imaging. Eur Heart J Cardiovasc Imaging 13 (2012), 922–930.
Detaint, D., Messika-Zeitoun, D., Avierinos, J.F., et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 111 (2005), 2391–2397.
Kerr, A.J., Raffel, O.C., Whalley, G.A., Zeng, I., Stewart, R.A., Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation. Eur Heart J 29 (2008), 363–370.
Klaar, U., Gabriel, H., Bergler-Klein, J., et al. Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation. Eur J Heart Fail 13 (2011), 163–169.
Rossi, A., Dini, F., Faggiano, P., et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 97 (2011), 1675–1680.
Pierard, L.A., Lancellotti, P., The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351 (2004), 1627–1634.
Lancellotti, P., Gerard, P.L., Pierard, L.A., Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 26 (2005), 1528–1532.
Lancellotti, P., Magne, J., Dulgheru, R., et al. Clinical significance of exercise pulmonary hypertension in secondary mitral regurgitation. Am J Cardiol 115 (2015), 1454–1461.
Lancellotti, P., Lebrun, F., Pierard, L.A., Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 42 (2003), 1921–1928.
Giga, V., Ostojic, M., Vujisic-Tesic, B., et al. Exercise-induced changes in mitral regurgitation in patients with prior myocardial infarction and left ventricular dysfunction: relation to mitral deformation and left ventricular function and shape. Eur Heart J 26 (2005), 1860–1865.
Lancellotti, P., Pierard, L.A., Chronic ischaemic mitral regurgitation: exercise testing reveals its dynamic component. Eur Heart J 26 (2005), 1816–1817.
Moonen, M., O'Connor, K., Magne, J., Lancellotti, P., Pierard, L.A., Stress echocardiography for selecting potential responders to cardiac resynchronisation therapy. Heart 96 (2010), 1142–1146.
Madaric, J., Vanderheyden, M., Van Laethem, C., et al. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. Eur Heart J 28 (2007), 2134–2141.
Senechal, M., Lancellotti, P., Magne, J., et al. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy. Am J Cardiol 106 (2010), 31–37.